PCR Perspectives
By PCR
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by PCR
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 53
Description
Stay at the forefront of interventions for valvular heart disease, coronary, and structural interventions with expert insights and perspectives. These interviews explore the techniques, tools, and key topics shaping the ever-evolving field of interventional cardiology
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
Long-term mortality following PCI with DES vs. CABG for left main disease
|
May 21, 2026 |
|
Coronary revascularisation in TAVI: meta-analysis of 4 Trials
|
May 21, 2026 |
|
LAA closure vs. NOAC in patients with atrial fibrillation across age groups in the CHAMPION AF study
|
May 21, 2026 |
|
What does ORBITA CTO tell us about CTO PCI?
|
May 20, 2026 |
|
The art of prompting, how to ask AI the right questions?
|
May 19, 2026 |
|
Why is TAVI a different procedure in patient with pure aortic regurgitation?
|
Apr 21, 2026 |
|
How to manage current challenges of small aortic annulus?
|
Apr 17, 2026 |
|
In what situation is emergency transcatheter valve intervention a valid alternative to surgery?
|
Apr 07, 2026 |
|
What are the key considerations for transcatheter mitral paravalvular leak management?
|
Mar 18, 2026 |
|
What are the key considerations when managing combined mitral and tricuspid regurgitation?
|
Feb 26, 2026 |
|
How are the 2025 ESC EACTS valvular guidelines going to impact my TAVI programme?
|
Feb 19, 2026 |
|
Should we consider TTVR in patients with straightforward anatomy who are eligible for T-TEER?
|
Feb 05, 2026 |
|
Is iatrogenic atrial septum defect closure a necessary procedure?
|
Jan 29, 2026 |
|
How to manage patients with aortic stenosis and coronary artery disease?
|
Jan 08, 2026 |
|
How are the 2025 ESC/EACTS valvular guidelines going to impact my mitral programme?
|
Dec 18, 2025 |
|
What are the key steps in pre procedural assessment for successful LAA closure?
|
Dec 11, 2025 |
|
The D-PACE scoring system - Can we predict high-grade conduction disturbances after TAVI?
|
Dec 04, 2025 |
|
How do we meet the needs of women with heart valve disease?
|
Nov 27, 2025 |
|
What are the key learnings from the 7-year follow-up of PARTNER 3?
|
Nov 21, 2025 |
|
How are the new 2025 ESC/EACTS valvular guidelines going to impact my tricuspid programme?
|
Nov 21, 2025 |
|
How to manage the challenges of TAVI in bicuspid disease?
|
Nov 13, 2025 |
|
What are the essentials of the provisional strategy for non-left main true bifurcation lesions?
|
Nov 13, 2025 |
|
EuroPCR 2025 Hotline - ACURATE neo2 under-expansion in the ACURATE IDE study: a post-hoc analysis
|
Nov 06, 2025 |
|
What is the latest in DCB practice?
|
Oct 30, 2025 |
|
Redo TAVI: how to treat different TAVI platforms when they fail?
|
Oct 23, 2025 |
|
What are the emerging indications for TAVI in 2025?
|
Oct 23, 2025 |
|
How will EARLY-TAVI and NOTION-3 impact TAVI practice?
|
Oct 16, 2025 |
|
Hotline from EuroPCR 2025 - Five-year outcomes from the Evolut low risk TAVR bicuspid study
|
Oct 16, 2025 |
|
Major EuroPCR 2025 LBT - 4D-ACS: one-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in acute coronary syndrome
|
Oct 09, 2025 |
|
How to manage treatment dilemmas in STEMI patients with multivessel disease?
|
Oct 09, 2025 |
|
What are the fundamentals of an upfront two-stent strategy for bifurcation PCI?
|
Oct 02, 2025 |
|
How to tailor transcatheter mitral therapies in 2025? A new era
|
Oct 02, 2025 |
|
How to successfully approach calcified bifurcation lesions?
|
Sep 25, 2025 |
|
Major LBTs from EuroPCR 2025 - Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies
|
Sep 18, 2025 |
|
How to implement the diagnosis of INOCA in everyday practice?
|
Sep 18, 2025 |
|
How to manage coronary artery disease in TAVI candidates?
|
Aug 27, 2025 |
|
How to efficiently and safely manage calcified left main disease
|
Aug 27, 2025 |
|
Vulnerable plaque PCI after PREVENT
|
Aug 27, 2025 |
|
FAITAVI - Major Late-Breaking Trial from EuroPCR 2025
|
Aug 21, 2025 |
|
First guidelines for the treatment of LM disease issued by SOLACI and SIAC
|
Aug 14, 2025 |
|
What are the essential aspects of transcatheter LAA closure?
|
Aug 07, 2025 |
|
How to successfully approach CTO interventions: a step-by-step approach
|
Jul 31, 2025 |
|
What is the optimal TAVI access approach in contemporary practice?
|
May 06, 2025 |
|
What do we know about bleeding risk & antithrombotic management after tricuspid valve interventions?
|
Apr 29, 2025 |
|
What are the key specific considerations for TAVI in women?
|
Apr 22, 2025 |
|
SAVR or TAVR: what is best for female patients?
|
Apr 15, 2025 |
|
Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair
|
Apr 08, 2025 |
|
Nurses and Allied Professionals: How to safely discharge your patient post TAVI?
|
Apr 01, 2025 |
|
How to manage the complexity of multivalve disease?
|
Mar 25, 2025 |
|
How to manage conduction disturbances after tricuspid valve interventions?
|
Mar 18, 2025 |
|
How can multi modality imaging contribute to the assessment of multivalve disease?
|
Mar 11, 2025 |
|
Nurses and Allied Professionals: How does frailty and cognition impact patient selection for TAVI?
|
Mar 04, 2025 |
|
Early detection and treatment of aortic stenosis
|
Feb 25, 2025 |